Health Secretary Robert F. Kennedy Jr.’s decision to revise COVID-19 vaccine guidance without first consulting the CDC’s established advisory board has caused widespread confusion among doctors, insurers, and health experts, multiple sources told Reuters.
In a video shared on social media last week, Kennedy — known for his long-standing skepticism about vaccines — declared that the government would no longer recommend COVID vaccinations for healthy children or pregnant women.
Soon after the video was posted, the CDC quietly modified its online childhood immunization schedule. The updated version indicated that healthy children can still receive the COVID shot if their parents and physicians believe it’s appropriate. The CDC also removed its prior recommendation for pregnant women to get vaccinated.
This shift bypassed the standard review process led by the CDC’s Advisory Committee on Immunization Practices (ACIP), a group of external experts that typically evaluates evidence in public meetings before making any formal recommendations. Their decisions usually guide what appears in the CDC’s immunization schedule, which influences what vaccines are covered under the Affordable Care Act.
“The surprise announcement has created uncertainty for payers and providers about whether the video posting constitutes an official policy change,” said Sarah Moselle, a principal with the healthcare consulting firm Avalere.
Until ACIP votes at its upcoming meeting from June 25–27, insurance companies are expected to delay any decisions about vaccine coverage, according to Robert Popovian, who leads Conquest Advisors, a healthcare consultancy.
Kennedy’s Department of Health and Human Services has defended the move, with a spokesperson stating that it was legally permissible and reflects a shift toward “clinical-guided decision making.”
The department added that it still values the input of expert panels like ACIP, which is scheduled to meet later this month, with the agenda to be released as is standard practice.
Ultimately, decisions about what is covered will be up to each insurance company, the HHS spokesperson added.
Historically, the CDC had recommended that everyone aged six months and older receive the COVID vaccine.
“This whole thing is so murky,” said a member of ACIP who spoke anonymously. “It’s very unclear whose decision is final.”
Dr. Tina Tan, president of the Infectious Diseases Society of America, warned that the inconsistent messaging is likely to lead to “significant confusion among medical professionals and the public.”
Dr. Matthew Zahn, a public health official in Orange County, California, who also advises the CDC panel, expressed the same concern. “We’re all awaiting clarity.”
“It’s going to be important to understand how these vaccines are insured,” Zahn said. “Specifically, if ultimately there is a recommendation for high-risk populations to be vaccinated, how that is interpreted by insurance companies and thus, how providers can recommend it.”
Zahn said he expects the CDC to provide further clarification soon but could not confirm whether that would happen at the upcoming ACIP meeting.
On Tuesday, Reuters reported that Dr. Lakshmi Panagiotakopoulos, a CDC specialist in pediatric infectious diseases who was deeply involved in coordinating the vaccine advisory group, had resigned. In a message to colleagues, she said she was stepping down because she was “no longer able to help the most vulnerable members” of the population.
Concerns have also been raised by the American College of Obstetricians and Gynecologists. On May 27, the group warned that removing the recommendation for pregnant women could make it more difficult for them to access the vaccine, “despite the clear and definitive evidence demonstrating its benefit.”
The CDC website notes that the Affordable Care Act typically mandates insurance coverage for vaccines included in the ACIP schedule.
Popovian warned that if insurers make decisions about coverage without clear guidance from ACIP, they could face significant risks. “It’s a liability,” he said. “Insurers need clarity on what they will be required to cover.”
A source familiar with the situation said the panel is expected to evaluate and vote on COVID vaccines for the fall and winter season at the upcoming meeting. The source also noted that the group has been leaning toward more limited recommendations.
{Matzav.com}